Migraine & Head TensionWhy Hasn't Anyone Brought Up Botox?
If you've been managing migraines for years, you've probably tried the standard options — preventive medications, trigger avoidance, rescue drugs taken at the first sign of an aura. And if you're still having 15 or more headache days a month, there's a reasonable question worth asking: why hasn't anyone brought up Botox?
Botox (onabotulinumtoxinA) received FDA approval for the prevention of chronic migraine in 2010. It has one of the strongest evidence bases of any preventive migraine treatment available. And yet it remains underutilized — often because patients don't know to ask, or because they associate Botox with cosmetic procedures rather than neurological ones. This page explains what chronic migraine is, how Botox works as a preventive treatment, what the clinical evidence shows, and what a treatment visit at Body Balance Medical looks like.
Scope statement: Body Balance Medical does not diagnose migraine disorder or neurological conditions. Patients with severe, new-onset, or changing headache patterns should be evaluated by their primary care provider or neurologist first. BBM's role is providing Botox treatment for patients who already have an established migraine diagnosis and have discussed preventive treatment options with their provider. This is not an emergency headache clinic.
- Botox is FDA-approved for the prevention of chronic migraine — defined as 15 or more headache days per month, with headaches lasting 4 or more hours, occurring for 3 or more consecutive months.
- Botox for chronic migraine works as a preventive treatment, not a pain reliever — it reduces the frequency of migraine days, not individual attack intensity.
- The PREEMPT clinical program, the two pivotal trials supporting FDA approval, found that onabotulinumtoxinA reduced headache days significantly more than placebo, with approximately 50% of patients experiencing a 50% or greater reduction in monthly headache days.
- Benefits accumulate across treatment cycles — most patients see meaningful results after the first or second round, with the full effect building over two to three cycles.
- Botox for episodic migraine (fewer than 15 headache days per month) and tension headaches is off-label — outside the FDA-approved indication, though supported by clinical use and literature.
What Chronic Migraine Actually Is
Chronic migraine has a specific clinical definition. It is not simply "bad migraines" or "frequent headaches." The diagnostic criteria require 15 or more headache days per month for at least three consecutive months, with at least 8 of those days meeting migraine criteria — head pain accompanied by features such as nausea, light sensitivity, or sound sensitivity, with or without aura.
This distinguishes chronic migraine from episodic migraine, where headache days are fewer than 15 per month. The distinction matters clinically because FDA approval for Botox applies specifically to chronic migraine. Botox for episodic migraine is off-label — meaning it may be used by clinicians based on their judgment, but FDA approval does not cover that indication.
Chronic migraine is a neurological disorder. It is underdiagnosed and undertreated, in part because patients often normalize high headache frequency over time. If you've reached the point where you're tracking your bad days and planning your week around them, that pattern warrants evaluation by a neurologist or physician who can establish a formal diagnosis. BBM does not provide that diagnosis. What BBM provides is the Botox treatment — for patients who arrive with an established diagnosis and a clear clinical picture. Patients with undiagnosed, worsening, or atypical headache patterns should be evaluated by a neurologist first.
For more on the neurotoxin treatments BBM offers, see the neurotoxin services page.
How Botox Prevents Migraines — Not Just Treats Pain
Botox is not a painkiller. It does not abort a migraine attack once it starts, and it does not work like a rescue medication taken at symptom onset. Botox for chronic migraine is a preventive treatment — its job is to reduce how often attacks occur, not to stop individual attacks in progress.
The mechanism is specific. OnabotulinumtoxinA is injected into targeted muscle groups around the head and neck, where it blocks the release of pain-signaling neurotransmitters — primarily calcitonin gene-related peptide (CGRP) and substance P — from peripheral nerve terminals. CGRP is a key driver of migraine neuroinflammation; when its release is suppressed at the peripheral level, the cascade of sensitization that triggers and sustains a migraine episode is interrupted before it fully activates.
In simpler terms: Botox is working upstream of the pain signal, at the point where nerves are sending the alarm, rather than downstream once the alarm is already sounding.
The FDA-approved protocol uses up to 31 injections across 7 muscle areas — the forehead, temples, back of the head, neck, and upper back — administered every 12 weeks. The injection sites follow a standardized map designed specifically for chronic migraine prevention. This is not the same protocol used for cosmetic Botox, and the dose is substantially higher.
What the Evidence Shows
The FDA approval for Botox in chronic migraine was supported by the PREEMPT clinical program — two large, multicenter, randomized, double-blind, placebo-controlled trials (Phase 3 REsearch Evaluating Migraine Prophylaxis Therapy).
The pooled results from both PREEMPT trials included 1,384 adults randomized to either onabotulinumtoxinA or placebo. At 24 weeks, patients receiving onabotulinumtoxinA experienced a mean reduction of 8.4 headache days per month, compared to 6.6 days in the placebo group — a statistically significant difference (P < .001). Significant improvements were also observed across secondary measures including migraine episode frequency, total cumulative hours of headache, and headache-related disability scores. (Aurora et al., Cephalalgia, 2010; pooled PREEMPT analysis, PMID 20487038.)
Across the PREEMPT program, approximately 50% of patients experienced a 50% or greater reduction in monthly headache days — a threshold commonly used in migraine research to define meaningful clinical response.
Two important caveats: First, benefits accumulate. The full effect of Botox for chronic migraine is not typically apparent after a single treatment cycle. Most patients notice improvement after the first or second round, with the response building over two to three treatment cycles. Second, not all patients respond. Botox is highly effective for many patients with chronic migraine — and it does not work for everyone. Individual response varies, and there is no reliable way to predict in advance who will be a strong responder. The goal is a meaningful reduction in headache frequency, not guaranteed elimination.
Tension Headaches and Jaw-Related Head Pain
Botox for tension-type headaches is off-label — outside the FDA-approved chronic migraine indication. That said, off-label use is a standard part of clinical practice, and the clinical literature increasingly supports Botox as a consideration for patients with frequent tension-type headaches that haven't responded adequately to other approaches.
One pattern worth understanding specifically: jaw clenching and masseter muscle tension — often associated with bruxism — can contribute directly to temporal and occipital head pain. The masseter is a large, powerful jaw muscle. When it's chronically overactive, the tension it generates can radiate upward through the temporalis muscle and into the base of the skull, producing headache patterns that patients often describe as pressure, tightness, or a band across the forehead and temples.
Masseter Botox, administered to reduce the force of jaw clenching, can interrupt this pattern for some patients. It is a different injection site and clinical rationale than the chronic migraine protocol — but the overlap in symptom presentation is real and worth discussing if your head pain is accompanied by jaw tightness, teeth grinding, or morning facial soreness. For more detail on how BBM approaches that specific pattern, see the jaw tension and bruxism page.
What a Treatment Visit Looks Like at Body Balance Medical
Botox migraine treatment at BBM is administered by Teresa Hernandez, MSN FNP-BC, Lead Aesthetic Injector and Biote-Certified provider. Teresa reviews your medical history, headache frequency and pattern, prior preventive treatments you've tried, and any contraindications before proceeding.
The injection protocol for chronic migraine covers the forehead, temples, back of the head, neck, and shoulders — following the FDA-approved PREEMPT injection map. Appointments typically take 20 to 30 minutes. Mild soreness or tenderness at injection sites is the most commonly reported side effect. There is no significant downtime — most patients return to normal activity the same day. Treatments are repeated every 12 weeks, consistent with the evidence-based protocol. Skipping cycles or extending intervals significantly beyond 12 weeks can reduce the cumulative benefit.
Before your appointment: BBM is an out-of-pocket clinic — insurance does not apply, and financing options are available. A migraine diagnosis should be established before scheduling — come prepared with headache history, current and prior preventive medications, and any neurology records that are relevant. This consultation is clinical, not cosmetic. Teresa's evaluation focuses on headache pattern, treatment history, and candidacy for the chronic migraine Botox protocol.
Is Botox for Chronic Migraine Right for You?
If you have a confirmed chronic migraine diagnosis, have tried at least one preventive medication with inadequate results, and are still experiencing 15 or more headache days per month — Botox migraine prevention is a clinically appropriate conversation to have. It has FDA approval, the clinical evidence to support it, and a well-defined treatment protocol with a strong real-world track record.
The fact that it's underutilized is a gap in awareness, not in evidence.
If you're not yet certain whether your headache pattern meets the chronic migraine threshold, start with a neurologist or your primary care provider. Once a diagnosis is established, BBM can discuss whether Botox prevention makes sense for your specific situation.
| Indication | FDA approval status | Notes |
|---|---|---|
| Chronic migraine (15+ days/month) | FDA-approved (2010) | Requires established diagnosis. Up to 31 injections every 12 weeks. |
| Episodic migraine (<15 days/month) | Off-label | Outside the approved indication; may be used at clinician's discretion. |
| Tension-type headaches | Off-label | Supported by clinical literature; discussed during consultation. |
| Jaw-related head pain (masseter) | Off-label for head pain | Masseter hypertrophy is FDA-approved; head pain relief is a secondary effect. |
Your Injector for Migraine Botox in Las Vegas
Teresa administers Botox for chronic migraine prevention using the FDA-approved PREEMPT injection map — a distinct clinical protocol from cosmetic Botox that covers the forehead, temples, back of the head, neck, and shoulders. She reviews headache history, prior preventive treatment records, and contraindications before any treatment is planned. Her focus during a migraine consultation is clinical: headache frequency, treatment pattern, and candidacy — not aesthetic outcomes. Treatments are repeated every 12 weeks at 7975 W Sahara Ave #101, Summerlin, Las Vegas. Better Balance, Better You includes fewer days lost to migraine.
Body Balance Medical is LegitScript Certified, verifying our prescribing and dispensing practices meet applicable laws and standards. All neurotoxin treatments are performed in-clinic at 7975 W Sahara Ave #101, Summerlin, Las Vegas.
Frequently Asked Questions About Botox for Migraines
Botox (onabotulinumtoxinA) is FDA-approved for the prevention of chronic migraine in adults — defined as 15 or more headache days per month, with headaches lasting 4 or more hours, occurring for 3 or more consecutive months. Botox for episodic migraine (fewer than 15 headache days per month) is off-label and not covered by the FDA approval for this indication.
The FDA-approved protocol uses up to 31 injections across 7 muscle groups — the forehead, temples, back of the head, neck, and upper back — administered every 12 weeks. This is substantially different from a cosmetic Botox treatment in both injection count and dose.
Most patients begin to notice a reduction in headache frequency after the first or second treatment cycle. The full preventive effect typically builds over two to three cycles — roughly six to nine months of treatment. Starting Botox and expecting immediate results after a single session sets up an inaccurate benchmark.
No. Botox for tension-type headaches is off-label. FDA approval covers chronic migraine only. That said, off-label use is clinically common, and many patients with frequent tension headaches have experienced meaningful symptom reduction. If jaw clenching or masseter tension is contributing to your head pain, that pattern may be a particularly relevant consideration — see BBM's jaw tension and bruxism page for more detail.
The most commonly reported side effects in the PREEMPT trials were mild to moderate and included neck pain, headache, and injection-site soreness. Serious adverse events were uncommon, and discontinuation due to adverse events occurred in 3.8% of patients receiving onabotulinumtoxinA across the pooled trials. Most patients tolerate the procedure well with no significant downtime.
No. Body Balance Medical is an out-of-pocket clinic. Insurance does not apply. Financing options are available for patients who need them. Contact the clinic directly at (702) 417-1261 for current details.
A formal referral is not required, but an established migraine diagnosis should be in place before scheduling. BBM does not diagnose migraine disorder. Patients with undiagnosed headache conditions, new-onset severe headaches, or new neurological symptoms should be evaluated by a primary care provider or neurologist first. Once a diagnosis is confirmed and your pattern clearly meets the chronic migraine criteria, BBM can discuss whether Botox prevention is appropriate.
Stop Planning Your Life Around Migraine Days
Botox has FDA approval, 15 years of clinical use, and PREEMPT trial data behind it. If you have an established chronic migraine diagnosis and 15 or more headache days a month, this conversation is worth having. Teresa Hernandez, MSN FNP-BC reviews your history and candidacy at our Summerlin clinic.
Schedule a ConsultationBetter Balance, Better You